Table 2.
Characteristics for the Full Sample and by Age Group
Full Sample (N = 9,389) | Aged 30–59 years (n = 6,603) | Aged 60–75 years (n = 2,786) | |
---|---|---|---|
Age (y), M | 47.46 (14.05) | 42.14 (9.65) | 66.86 (4.21) |
Female (%) | 51.83 | 51.23 | 54.01 |
Died, (N) | 1,843 | 566 | 1,277 |
Censored, (N) | 7,546 | 6,037 | 1,509 |
Person-years (M) | 14.17 (3.35) | 14.65 (2.83) | 12.43 (3.92) |
C-reactive protein (mg/dL), M | 0.42 (0.67) | 0.39 (0.60) | 0.53 (0.79) |
Creatinine (mg/dL), M | 1.07 (0.29) | 1.05 (0.29) | 1.14 (0.27) |
Glycated hemoglobin (%), M | 5.42 (1.08) | 5.33 (1.08) | 5.76 (1.02) |
Albumin (g/dL), M | 4.16 (0.38) | 4.19 (0.40) | 4.06 (0.30) |
Total cholesterol (mg/dL), M | 209.36 (46.20) | 204.99 (47.14) | 225.29 (40.46) |
Cytomegalovirus optical density, M | 1.78 (1.29) | 1.66 (1.38) | 2.25 (0.93) |
Alkaline phosphatase (U/L), M | 81.66 (32.59) | 79.24 (31.90) | 90.50 (32.84) |
Forced expiratory volume (mL), M | 3102.16 (1002.91) | 3304.69 (979.62) | 2363.82 (705.09) |
Urea nitrogen (mg/dL), M | 14.38 (5.28) | 13.71 (4.97) | 16.82 (5.34) |
Systolic blood pressure, M | 123.13 (18.77) | 119.47 (17.18) | 136.49 (16.90) |